Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-01-05 to 2022-01-06
Current total value of award: $58575
Description: 4556348668!HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML